Effects of SGLT2is on cardiovascular death and all-cause death in patients with diabetic nephropathy: a meta-analysis of randomized controlled trials

Authors :: Li-Min Zhao
Mei Qiu
Liang-Liang Ding
Ze-Lin Zhan
Publication Year :: 2021
Publisher :: INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2021.

Subjects :: medicine.medical_specialty
business.industry
medicine.disease
law.invention
Diabetic nephropathy
Cardiovascular death
Randomized controlled trial
law
Meta-analysis
Internal medicine
medicine
In patient
business
All cause mortality

Full Text Access

Tools